Death by neglect as a deletional mechanism of peripheral tolerance

International Immunology

Volumn 11, Issue 8, 1999, Pages 1225-1237

  Bertolino, Patrick ^a,b   Trescol Biémont, Marie Claude ^b   Thomas, Joëlle ^b   Fazekas De St Groth, Barbara ^a   Pihlgren, Maria ^b   Marvel, Jacqueline ^b   Rabourdin Combe, Chantal ^b  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Activation induced cell death; Co stimulation; Hepatocytes; T lymphocytes; Tolerance

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2; MESSENGER RNA; PROTEIN BCL X;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; GENE EXPRESSION; LIVER CELL; LIVER PARENCHYMA; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD28; APOPTOSIS; BCL-X PROTEIN; CD8-POSITIVE T-LYMPHOCYTES; CLONAL DELETION; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; INTERLEUKIN-2; LIVER; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SELF TOLERANCE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0345004951     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.8.1225     Document Type: Article

References (72)

1. Liu, Y. and Linsley, P. S. 1992. Co-stimulation of T cell growth. Curr. Opin. Immunol. 4:265.
2. June, C., Bluestone, J. A., Nadler, L. M. and Thompson, C. B. 1994. The B7 and CD28 receptor families, Immunol. Today 15:321.
3. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell co-stimulation. Immunity 2:555.
4. Fraser, J. D., Irving, B. A., Crabtree, G. R. and Weiss, A. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
5. Jenkins, M. K., Taylor, P. S., Norton, S. D. and Urdahl, K. B. 1991. CD28 delivers a co-stimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
6. Lindsten, T., June, C. H., Ledbetter, J. A., Stella, G. and Thompson, C. B. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
7. L. Immunity 3:87.
8. Radvanyi, L., Shi, Y., Vaziri, H., Sharma, A., Dhala, R., Mills, G. and Miller, R. G. 1996. CD28 co-stimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788.
9. Schwartz, R. H., Mueller, D. L., D., J. M. and Quill, H. 1989. T cell clonal anergy. Cold Spring Harbor Symp. Quant. Biol. 54:605.
10. Sagerstrom, C. G., Kerr, E. M., Allison, J. P. and M., D. M. 1993. Activation and differentiation requirements of primary T cells in vitro. Proc. Natl Acad. Sci. 90:8987.
11. Shahinian, A., Pfeffer, K., Lee, K. P., Kundig, T. M., Kishihara, K. Wakeham, A., Kawai, K., Ohashi, P. S., Thompson, C. B. and Mak, T. M. 1993. Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261:609.
12. Kündig, T. M., Shahinian, A., Kawai, K., Mittrüker, H., Sebzda, E., Bachmann, M. F., Mak, T. W. and Ohashi, P. S. 1996. Duration of TCR stimulation determines co-stimulatory requirement of T cells. Immunity 5:41.
13. Mittrucker, H. W., Shahinian, A., Bouchard, D., Kunding, T. M. and Mak, T. W. 1996. Induction of unresponsiveness and impaired T cell expansion by staphyloccocal enterotoxin B in CD28-deficient mice. J. Exp. Med. 183:2481.
14. Lespagnard, L., Mettens, P., De Smedt, T., Bazin, H., Urbain, J., Leo, O. and Moser, M. 1998. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance. Int. Immunol. 10:295.
15. Sperling, A. I., Auger, J. A., Ehst, B. D., Rulifson, I. C., Thompson, C. B. and Bluestone, J. A. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
16. Schónrich, G., Kalinke, U., Mornburg, F., Malissen, M., Scmitt-Verhulst, A. M., Malissen, B., Hämmerling, G. and Arnold, B. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293.
17. b in the liver. Eur J Immunol 25:1932.
18. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. A. P. and Kosaka, H. 1996. Constitutive class-I restricted exogenous presentation of self-antigens in vivo. J. Exp. Med. 184:923.
19. Heath, W. R., Allison, J., Hoffmann, M. W., Schonrich, G., Arnold, B. and Miller, J. F. A. P. 1992. Autoimmunity to extra-thymic antigens as a consequence of local production of interleukin-2. Nature 359:547.
20. + T cells is transient and depends on avidity. J. Immunol. 25:2339.
21. Guerder, S., Picarella, D. E., Linsley, P. and Flavell, R. A. 1994. Co-stimulator B7.1 confers antigen-presenting cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl Acad. Sci. USA 91:5138.
22. Harlan, D. M., Hengartner, H., Huang, M. L., Kang, Y., Abe, R., Moreadith, R. W., Pircher, H., Gray, G. S., Ohashi, P. S., Freeman, G. J., Nadler, L. M., June, C. J. and Aichele, P. 1993. Mice expressing both B7.1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc. Natl Acad. Sci. USA. 91:3137.
23. Guerder, S., Mayerhoff, J. and Flavell, R. A. 1994. The role of T cell co-stimulator B7.1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen. Immunity 1:155.
24. Soldevila, G., Geiger, T. and Flavell, R. A. 1995. Breaking immunologic tolerance to an antigenic peptide of simian virus 40 large antigen. J. Immunol. 155:5590.
25. Goresky, C. A., Huet, P, and Villeneuve, J. P.1982. Blood-tissue exchange and blood flow in the liver. In Zakim, D., ed., Hepatology: A Textbook of Liver Disease, p. 32. Saunders, Philadelphia, PA.
26. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
27. Ando, K., Guidotti, L. C., Cerny, A., Ishikawa, T. and Chisari, F. V. 1994. CTL access to tissue antigen is restricted in vivo. J. Immunol. 153:482.
28. Crispe, I. N. and Mehal, W. Z. 1996. Strange brew: T cells in the liver. Immunol. today 17:522.
29. Bertolino, P., Trescol-Biemont, M. C. and Rabourdin-Combe, C. 1998. Hepatocytes induce full activation of naive CD8 T cells but fail to promote survival. Eur. J. Immunol. 28:221.
30. Singer, G. G. and Abbas, A. K. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
31. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. and Krammer, P. H. 1995. Autocrine T cell suicide mediated by APO-1/Fas. Nature 373:438.
32. Brunner, T., Mogil, R. G., Laface, D., Yoo, N. J., Mahoubl, A., Echeverri, F., Martin, F., Force, W. R., Lynch, D. H., Ware, C. F. and Green, D. R. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373:441.
33. + T cells. Int. Immunol. 8:675.
34. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
35. Speiser, D. E., Sebzda, E., Ohteki, T., Bachmann, M. F., Pfeffer, K., Tak, M. W. and Ohashi, P. S. 1996. Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytes in vivo. Eur. J. Immunol. 26:3055.
36. L on activated T cells and can be prevented by CD28 co-stimulation. J. Immunol. 158:598.
37. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188:415.
38. Ehl, S., Hoffmann-Rohrer, U., Nagata, S., Hensgartner, H. and Zinkernagel, R. 1996. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. J. Immunol. 156:2357.
39. Lenardo, M. J. 1991. Interleukin-2 programs mouse αß T lymphocytes for apoptosis. Nature 353:858.
40. Boehme, S. A. and Lenardo, M. J. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 149:1552.
41. Strasser, A., Harris, A. W., Huang, D. C. S., Krammer, P. H. and Cory, S. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:6136.
42. Memon, S. A., Moreno, M. B., Petrak, D. and Zacharchuk, C. M. 1995. Bcl-2 blocks glucocorticoid-but not Fas-or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644.
43. Van Parijs, L., Ibraghimov, A. and Abbas, A. 1996. The roles of co-stimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
44. Cohen, J. J., Duke, R. C., Fadok, V. A. and Sellins, K. S. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267.
45. Mogil, R. J., Radvanyi, L. G., Gonzales-Quintial, R., Miller, R. G., Mills, G. B., Theophilopoulos, A. N. and Green, D. R. 1995. Peripheral T cell deletion and associated apoptosis in vivo is defective in young lpr mice. Int. Immunol. 7:1451.
46. S) gene expression. Eur. J. Immunol. 26:294.
47. Hua, C., Boyer, C., Guimezanes, A., Albert, F. and Schmitt-Verhulst, A. M. 1986. Analysis of T cell activation requirements with the use of alloantigens or an anti-clonotypic monoclonal antibody. J. Immunol. 136:1927.
48. Dialynas, D., Quan, Z., Wall, K., Pierres, A., Quintans, J., Loken, M., Pierres, M. and Fitch, F. 1983. Characterization of the murine T cell surface molecule, designated L3T4 identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445.
49. Coffman, R. L. 1982. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:5.
50. Bhattacharya, A., Dorf, M. E. and Springer, T. A. 1981. A shared alloantigenic determinant on la antigens encoded by the IA and IE subregions: evidence of I region gene duplication. J. Immunol. 127:2488.
51. Springer, T., Galfre, G., Secher, D. S. and Milstein, C. 1978. Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens. Eur J. Immunol. 8:539.
52. Holmes, K. L., Langdon, W. Y., Fredrickson, T. N., Coffman, R. L., Hoffman, P. M., Hartley, J. W. and Morse, H. C. 1986. Analysis of neoplasms induced by CAS-BR-M MULV tumour extracts. J. Immunol. 137:679.
53. Gerlier, D. and Thomasset, N. 1986. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 94:57.
54. Shire, D., Legoux, P. and Minty, A. 1997. Standardisation of messenger RNA quantification using an RT-PCR method involving coamplification with a multi-specific internal control. In Lassner, D., Pustowoit, B. and Rolfs, A., eds, Modern Applications of DNA Amplification Techniques: Problems and New Tools, p. 25. Plenum, New York
55. Boise, L. H., Gonzales-Garcia, M., Rostema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G. and Thompson, C. B. 1993. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597.
56. Deng, G. and Podack, E. C. 1993. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl Acad. Sci. USA 90:2189.
57. Broome, H. E., Dargan, C. M., Krajewski, S. and Reed, J. C. 1995. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J. Immunol. 155:2311.
58. Oltvai, Z. N., Milliman, C. L. and Korsmeyer, S. J. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609.
59. Alexander-Miller, M. A., Leggatt, G. R., Sarin, A. and Berzofsky, J. A. 1996. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med. 184:485.
60. Hitoshi, Y., Lorens, J., Kitada, S. I., Fisher, J., M., L., Ring, H. Z., Francke, U., Reed, J. C., Kinoshita, S. and Nolan, G. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8:461.
61. Tschopp, J., Irmler, M. and Thome, M. 1998. Inhibition of fas death by FLIPs. Curr Opin. Immunol. 10:552.
62. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S. and Tanigushi, N. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
63. Klas, C., Debatin, K. M., Jonker, R. R. and Krammer, P. H. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
64. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334.
65. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmeyer, S. J. 1990. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144:3602.
66. van Parijs, L. and Abbas, A. K. 1996. Role of Fas-mediated cell death in the regulation of immune responses. Curr. Opin. Immunol. 8:355.
67. Boise, L. H. and Thompson, C. B. 1996. Hierarchical control of lymphocyte survival. Science 274:67.
68. Zuckerman, L. A., Pullen, L. and Miller, J. 1998. Functional consequences of co-stimulation by ICAM-1 on IL-2 gene expression and T cell activation. J. Immunol. 160:3259.
69. Yashiro, T., Tai, X., Toyo-oka, K., Park, C., A, R., Hamaoka, T., Kobayashi, M., Neben, S. and Fujiwara, H. 1998. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules. Eur J. Immunol. 28:926.
70. + T cells are poorly co-stimulated by ICAM-1. Eur. J. Immunol. 29:45.
71. Calne, R. Y., Sells, R. A., Pena, J. R., Davis, D. R., Millard, P. R., Herbertson, B. M., Binns, R. M., and Davies, D. A. L. 1969. Induction of immunological tolerance by porcine liver allografts. Nature 223:472.
72. Kamada, N., Davies, H. f. S. and Roser, B. 1981. Reversal of transplantation immunity by liver grafting. Nature 292:840.